GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gemina Laboratories Ltd (XCNQ:GLAB) » Definitions » Deferred Tax

Gemina Laboratories (XCNQ:GLAB) Deferred Tax : C$0.00 Mil (TTM As of Jan. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Gemina Laboratories Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Gemina Laboratories's change in deferred tax for the three months ended in Jan. 2024 was C$0.00 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Jan. 2024 was C$0.00 Mil.

Gemina Laboratories Deferred Tax Historical Data

The historical data trend for Gemina Laboratories's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gemina Laboratories Deferred Tax Chart

Gemina Laboratories Annual Data
Trend Jan21 Jan22 Jan23 Jan24
Deferred Tax
- - - -

Gemina Laboratories Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Gemina Laboratories Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gemina Laboratories Deferred Tax Related Terms

Thank you for viewing the detailed overview of Gemina Laboratories's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Gemina Laboratories (XCNQ:GLAB) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gemina Laboratories Ltd (XCNQ:GLAB) » Definitions » Deferred Tax
Comparable Companies
TSX:ATE TSXV:GSD TSX:MBX TSX:TH TSXV:TTI XCNQ:ACOG TSXV:MSCL TSXV:COV TSX:APS TSXV:CZO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
GLABF:USA
Address
3800 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8
Website
https://www.geminalabs.com
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.
Executives
James Damian Tansey Director

Gemina Laboratories (XCNQ:GLAB) Headlines

No Headlines